CN
69-65-8
应用筛选条件
关键词:'69-65-8'
显示 1-30 共 397 条结果 关于 "69-65-8" 范围 技术文档
SMC®Plate Washer Evaluation Kit
5 6 7 8 9 10 11 12 Row Mean SD CV
A 68 65 86 57 71 79 61 79 59 69 59 82 70 10 14
B 79 55 63 62 60 60 52 49 64
The Effective Use of Protein Kinase Inhibitors
63 98 105 83 69
90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21 34 99 78 85 79
91 96 86 98 58 68 46 7 97 22 11
Aldrich Polymer Products Application - Initiators
Solvent)
44,146-5 tert-Amyl peroxybenzoate 99 (benzene)
11,816-8 4,4-Azobis(4-cyanovaleric acid) Acetone 70 4.6 x 10-5 69 (water)
Water 69 1.9 x 10-5
Water 80 9.0 x 10-5
38,021-0 1,1'-Azobis(cyclohexanecarbonitrile
Data Sheet - G5163
Acid Decarboxylase 65/67 (G5163) - Data Sheet
Anti-Glutamic Acid Decarboxylase 65/67
produced in rabbit, IgG fraction of antiserum
Catalog Number G5163
Synonym: Anti-GAD 65/67
Product Description
Data Sheet - G1166
system, suggesting its involvement in development and
plasticity.8 GAD exists as two isoforms, GAD65 and
GAD67 (molecular masses of 65 and 67 kDa,
respectively) that are encoded by two different
genes
Data Sheet - G4913
ACID DECARBOXYLASE 65
(GAD 65, 514-530)
Developed in Rabbit, IgG Fraction of Antiserum
Product Number G4913
Product Description
Anti-Glutamic Acid Decarboxylase 65 (GAD 65, 514-
530) is developed
The Effective Use of Protein Kinase Inhibitors
63 98 105 83 69
90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21 34 99 78 85 79
91 96 86 98 58 68 46 7 97 22 11
Data Sheet - G5038
ACID DECARBOXYLASE 65
(GAD 65, 5-22)
Developed in Rabbit, IgG Fraction of Antiserum
Product Number G5038
Product Description
Anti-Glutamic Acid Decarboxylase 65 (GAD 65, 5-22),
is developed
Quality Control Ranges: MILLIPLEX® MAP Bovine Cytokine/Chemokine Magnetic Bead Panel
IL-6 Control 1 76 - 158 pg/mL MIP-1β Control 1 65 - 135 pg/mL
Control 2 384 - 797 pg/mL Control 2 394 - 819 pg/mL
Data Sheet - F9890
R., et al., Immunol. Lett., 10, 223-252,
(1985)
3. Stevens, R., et al., J. Clin. Immunol., 3, 65-69
(1985).
4. Van der Meulen, F.W., et al., Brit. J. Haematol., 46,
47-56 (1980).
5. Oxelius
Data Sheet - F9902 - Lot 014K4837
Dyr, J., et al., Thromb. Res., 65, Suppl. 1, S209
(1992).
3. Suttnar, J., et al., Thromb. Haemost., 69, 1156
(1993).
4. Marecek, F., et al., Thromb. Haemost., 69, 1262
(1993).
5. Haverkate
Data Sheet - F9902 - Lot 014H4837
. Dyr, J., et al., Thromb. Res., 65, Suppl. 1, S209
(1992).
3. Suttnar, J., et al., Thromb. Haemost., 69, 1156
(1993).
4. Marecek, F., et al., Thromb. Haemost., 69, 1262
(1993).
5. Haverkate, F
Data Sheet - F9902
Dyr, J., et al., Thromb. Res., 65, Suppl. 1, S209
(1992).
3. Suttnar, J., et al., Thromb. Haemost., 69, 1156
(1993).
4. Marecek, F., et al., Thromb. Haemost., 69, 1262
(1993).
5. Haverkate
LABORATORY NOTEBOOK ISSUANCE PAGE
.387
Hexane 0.659 69 –95 –23 0.31 1.89 200 1.375
Hexanes 0.672 68–70 — –22 — — 210 1.379
2–Methoxyethanol 0.965 124–125 –85 46 1.72 16.9 210 1.402
2–Methoxyethyl acetate 1.009 145 –65 43 — — 254 1.402
Methyl
Lab Notebook Guidelines
.387
Hexane 0.659 69 –95 –23 0.31 1.89 200 1.375
Hexanes 0.672 68–70 — –22 — — 210 1.379
2–Methoxyethanol 0.965 124–125 –85 46 1.72 16.9 210 1.402
2–Methoxyethyl acetate 1.009 145 –65 43 — — 254 1.402
Methyl
Product Information Sheet - H6008
(1), 1-8 (1972).
4. Lindqvist, B., et al., Preparative fractionation of
triglyceride mixtures according to acyl carbon
number, using hydroxyalkoxypropyl Sephadex.
J. Lipid Res., 15(1), 65-73 (1974
LABORATORY NOTEBOOK ISSUANCE PAGE
.387
Hexane 0.659 69 –95 –23 0.31 1.89 200 1.375
Hexanes 0.672 68–70 — –22 — — 210 1.379
2–Methoxyethanol 0.965 124–125 –85 46 1.72 16.9 210 1.402
2–Methoxyethyl acetate 1.009 145 –65 43 — — 254 1.402
Methyl
Omega-Conotoxin MVIIC (C4188)
Hillyard, D.R. et al., A new Conus peptide ligand for
mammalian presynaptic Ca2+ channels. Neuron, 9,
69-77 (1992).
Sold under license from Cognetix for research purposes
only; subject to US patent no
LABORATORY NOTEBOOK ISSUANCE PAGE
.387
Hexane 0.659 69 –95 –23 0.31 1.89 200 1.375
Hexanes 0.672 68–70 — –22 — — 210 1.379
2–Methoxyethanol 0.965 124–125 –85 46 1.72 16.9 210 1.402
2–Methoxyethyl acetate 1.009 145 –65 43 — — 254 1.402
Methyl
Product Information Sheet - H6383
(1), 1−8 (1972).
4. Lindqvist, B., et al., Preparative fractionation of
triglyceride mixtures according to acyl carbon
number, using hydroxyalkoxypropyl Sephadex.
J. Lipid Res., 15(1), 65−73 (1974
NovAseptic®Mixer, Tank Plate, GMP and HS
—
4
(0.16)
1
(0.04)
1.8
(0.07) GMP500
GM10/33 62 (2.44)
150
(5.91)
69
(2.72)
58
(2.28)
65
(2.56)
110
(4.33)
17
(0.67)
56
(2.20) M6 45º
125
59505 Galactosyltransferase Kit
D-glucopyranoside)
15
65
65
Product Information Sheet - F9890
., et al., Immunol. Lett., 10, 223 252,
(1985)
3. Stevens, R., et al., J. Clin. Immunol., 3, 65 69
(1985).
4. Van der Meulen, F.W., et al., Brit. J. Haematol.,
46, 47 56 (1980).
Data Sheet - C0430 - Lot 121K8801
10000
20000
30000
40000
50000
60000
70000
m/z
Abundance
42
51
55 65
69 78 91
98
106
118
133
147
161
176
Hewlett-Packard 5890 Series
NovAseptic®Mixer: Tank Plate, GMP ATEX Specification
0.16)
1
(0.04)
1.8
(0.07)
GMP500 ATEX
AX10/33 62
(2.44)
150
(5.91)
69
(2.72)
58
(2.28)
65
(2.56)
110
(4.33)
17
(0.67)
56
(2.20)
M6 45º 125
(4.92)
Mouse Anti-Wilms Tumor WT-1
at 2-8°C.
REFERENCES: Huff V. Am J Med Genet 1998 Oct 2;79(4):260- 267.
Bruening W, et al. Nat Genet 1992 May;1(2):144-148.
Schedl A, Hastie N. Mol Cell Endocrinol 1998 May 25;140(1-2):65-69.
Data Sheet - A4095
Monoclonal Anti-phospho-ATF2 (pT69,71) reacts specifi-
cally with ATF2 phosphorylated at both threonine 69
and 71, and does not detect the monophosphorylated
and the non-phosphorylated ATF2 molecule. The
(A1577) - Product Information -
Nail, S. L., et al., Kinetics of acid neutralization by
aluminum hydroxide gel. J. Pharm. Sci., 65(8),
1255-1258 (1976).
7. Geurts, F. L., et al., Encapsulation of aluminium
hydroxide fillers with
Data Sheet - 63237
susceptibility testing for Mycobacterium tuberculosis, Clinical
Microbiology Newsletter, 17, 65-69 (1995)
Precautions and Disclaimer
Product Information Sheet - P9763
, K. F. and Cantley, L. C., Pathways for
phosphoinositide synthesis. Chem. Phys. Lipids,
98(1-2), 69-77 (1999).
3. Vanhaesebroeck, B. and Waterfield, M.D.,
Signaling by distinct classes of phosphoinositide
1/14